NFE2L2 mutations have recently been shown to define subtypes with differential prognosis in lung and head and neck cancers (Frank et al,2018; Namani et al,2018; Xu et al,2020; Liu et al,2020b). The gene discussed is NFE2L2; the disease is head and neck cancer.